Exosomal miRNA‐166‐5p derived from G‐MDSCs promotes proliferation by targeting ITM3E in colorectal cancer

Abstract

AbstractBackgroundThe immune milieu of colorectal cancer is a complex phenomenon. It is imperative to investigate the crucial immune factors that promote the progression of colorectal cancer. Immune suppressor cells are granulocytic myeloid‐derived suppressor cells (G‐MDSCs). However, they also increased cancer growth in other ways that need to be investigated further.MethodsUsing flow cytometry, we isolated G‐MDSCs from colorectal cancer tissues. Ultracentrifugation was used to separate exosomes from the supernatant of G‐MDSCs, and western blotting, transmission electron microscopy (TEM), and flow cytometry were used to confirm their presence. RNA sequencing was used to identify unique miRNAs and transcripts, which were subsequently confirmed by RT‐qPCR (real‐time quantitative real‐time PCR). The CCK‐8 test was used to determine the rate of proliferation. Lentiviral vectors were employed to manipulate the expression of miRNAs and genes in order to investigate their role in the development of colorectal cancer.ResultsColorectal cancer tissues have been found to contain granulocyte‐myeloid‐derived suppressor cells (G‐MDSCs) that secrete exosomes. These exosomes have been shown to accelerate cancer progression by promoting cell proliferation. Further research has identified microRNA‐166‐5p as a target from G‐MDSC‐derived exosomes. This downregulation leads to the inhibition of integral membrane protein 2B (ITM3E) transcription, which in turn activates the PI3K/Akt signaling pathway. This pathway promotes cell proliferation and can be inhibited using deguelin. The accelerated development of colorectal cancer has been further confirmed in mice models.ConclusionThe primary results of this work show that exosomes produced from G‐MDSCs and the miR‐166‐5p/ITM3E axis have therapeutic and diagnostic promise in colorectal cancer.